bedside glucose monitoring

bedside glucose monitoring

A format for measuring glucose, in which blood is obtained from the patient and measured immediately. It has been claimed that BGM reduces hospital stays and hospitalisation costs for patients with diabetic ketoacidosis and those in ITU/ICU.

bedside glucose monitoring

Endocrinology A format for measuring glucose, in which blood is obtained from the Pt and measured immediately; it has been claimed that BGM results in ↓ hospital stays and hospitalization costs for Pts with DKA.  See Point-of-care testing.
References in periodicals archive ?
Pivotal Trial to Build on Previous Positive Studies; Aims to Further Demonstrate Paradigm-Shifting Potential of Automated, Bedside Glucose Monitoring System in the ICU
The OptiScanner 5000 is the company's first-of-its-kind automated, bedside glucose monitoring system that provides physicians with critical information to manage patient glucose levels in the ICU.
For example, during The Joint Commission's triennial survey of the hospital two months before, the surveyor observed an ICU phlebotomist drawing blood samples from a patient who had also just completed a fingerstick for bedside glucose monitoring.
The Joint Commission surveyor was very impressed with the speed of the laboratory's turnaround time, as well as the close correlation between the results from the bedside glucose monitoring and the blood analysis from the laboratory," says Denise Uettweiller-Geiger, PhD, administrative director of the laboratory.
Evaluation of the bedside glucose monitoring system in neonatal units.
The frequency of bedside glucose monitoring has also increased, and the number of instances requiring the care of the rapid-response team has dropped.
5) Other Q-Probes studies have shown that, compared to the utilization of nonlaboratory personnel, utilization of laboratory personnel resulted in faster emergency department stat test turnaround times, (12,13) more accurate bedside glucose monitoring, more reliable quality control of bedside glucose monitors, (14-16) and fewer unsatisfactory and rejected chemistry (17) and complete blood count laboratory specimens.
Industry Thought-Leaders Highlight Paradigm-Shifting Potential of Automated, Bedside Glucose Monitoring System for Critically Ill Patients
BRUSSELS, March 21, 2012 /PRNewswire/ --OptiScan Biomedical Corporation, a developer of innovative continuous glucose monitoring systems for use in intensive care units (ICU), announced positive clinical study data for the OptiScanner[TM], the company's first-of-its-kind automated, bedside glucose monitoring system.
Bedside glucose monitoring data analysis and critique.
The company's lead product is the OptiScanner[TM], a first-of-its-kind automated, bedside glucose monitoring system that provides highly accurate, continuous monitoring of patients' glucose levels measured in plasma, as opposed to whole blood.
19, 2011 /PRNewswire/ -- OptiScan Biomedical Corporation, a developer of innovative continuous glucose monitoring systems for use in intensive care units (ICU), today announced that the company's OptiScanner(TM) Automatic Bedside Glucose Monitoring System has received CE Mark certification for use in the European Union.